Psoriasis Treatment And Infection Risk: Why IL-17 Inhibitors Stand Out
A nationwide study of 18,635 psoriasis patients found different infection risks across treatments, with IL-17 inhibitors linked to higher candidiasis risk.
A nationwide study of 18,635 psoriasis patients found different infection risks across treatments, with IL-17 inhibitors linked to higher candidiasis risk.
